About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05165524

Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation

The treatment of leg veins and varicosis with sclerotherapy is one of the most frequently performed medical intervention in the western world. The most common local side effects of this treatment are ...

Lead sponsor: Insel Gruppe AG, University Hospital Bern•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Insel Gruppe AG, University Hospital Bern

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Fitzpatrick skin type I-IV
•Presence of at least 1 postinflammatory hyperpigmentation after sclerotherapy

Exclusion Criteria

•History of adverse events related to short-pulsed laser therapy
•Pregnant or breast-feeding women
•Intention to become pregnant during the course of the study
•History of intolerance or allergic reaction to triple cream or one of its ingredients
•Prior treatment with parenteral gold therapy
•Inability to understand the study content

Related studies

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

NCT05362929 · Acne Scars - Mixed Atrophic and Hypertrophic, Hyperpigmentation, and more

Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins

NCT06253468 · Hyperpigmentation

Pilot Study of LED for PIE and PIH

NCT06349447 · Hyperpigmentation

Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

NCT06320314 · Hyperpigmentation

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

NCT03646955 · Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 19, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment66

Start dateMar 2022

Last updatedMar 19, 2025

Condition

Hyperpigmentation Varicosis

Locations shown

Department of dermatology, University Hospital Inselspital, Bern

Bern

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2025Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions